Potassium Magnesium Aspartate Oral Solution

Aspartic acid (Asp), also known as aspartic acid, contains two carboxyl groups and one amino group in its molecule. It is an acidic amino acid and is widely present in all proteins. Aspartic acid is a precursor of oxaloacetate and plays an important role in the tricarboxylic acid cycle, ornithine cycle and nucleotide synthesis. It has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability of cells such as nervous tissue, myocardium, and smooth muscle and the stability of the internal environment. It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders. Aspartic acid participates in the ornithine cycle, promotes urea production, and reduces ammonia and

This product is an aqueous solution of L-aspartic acid, magnesium oxide and potassium hydroxide. The content of aspartic acid (C4H7NO4), potassium (K) and magnesium (Mg) should be 90.0-110.0% of the labeled amount.

This product is a colorless or light brown clear liquid.

Electrolyte supplement. Suitable for hypokalemia, improving symptoms of poisoning such as arrhythmia, nausea, vomiting caused by digitalis poisoning, for various heart diseases such as sequelae of myocarditis and chronic heart failure, and can also be used as an auxiliary treatment for acute and chronic hepatitis, cirrhosis, insufficient bile secretion and hepatic encephalopathy. 1 Cardiovascular system diseases (1) Arrhythmia and tachycardia caused by various reasons in adults and children, as well as arrhythmia caused by digitalis poisoning; (2) Myocardial infarction, coronary heart disease, angina pectoris, hypertension, etc.; (3) Myocardial damage caused by tumor chemotherapy. 2 Digestive system diseases Acute and chronic hepatitis, jaundice,

Oral administration, 1 tablet at a time, 3 times a day.

Nausea may occur occasionally, but will resolve after medication is discontinued.

It is contraindicated in patients with hyperkalemia, hypermagnesemia, severe renal dysfunction and severe atrioventricular block.

Not yet clear.

Keep away from light.

10ml

Suzhou Pharmaceutical Factory

• Founded in:

  2006-02-14

• Address:

  No. 2-1, Dongwu South Road, Wuzhong District, Suzhou City

• Tax NO.:

  91320506138170408U

• Registered Funds:

  -

• Website:

  Log in to view

• Email:

  Log in to view